PRPHOTCPharmaceutical PreparationsFiscal year ends December 31

ProPhase Labs, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.01−0.00 (-6.16%)

Close on Oct 19, 2026

Market cap: $119.68K
P/E (TTM): –
Dividend yield: –

ProPhase Labs, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	0.09	0.68	1.61	9.11	8.66	6.82	0.43	1.55	3.17	0.44	1.66	2.93	1.64	0.57	5.54	8.23	13	12
Short-Term Investments	0	3.13	3.13	8.33	8.78	1.64	0.93	6.69	19	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	0.09	0.70	5.30	17	17	8.46	1.36	8.24	22	0.44	1.66	2.93	1.64	0.57	5.54	8.23	13	12
Receivables	1.54	20	36	37	38	3.16	2.01	2.97	1.95	5.77	4.00	5.84	5.32	5.41	3.22	4.82	–	–
Inventory	0.07	1.14	2.29	3.98	4.60	3.04	1.46	1.90	1.53	2.74	4.33	3.29	2.52	2.05	2.69	1.68	–	–
Prepaid Expenses & Other	1.45	2.62	1.96	2.37	1.50	1.24	0.30	0.30	0.48	0.68	1.88	1.40	1.80	2.69	1.75	0.88	–	–
Total Current Assets	3.15	31	48	61	61	16	9.95	18	28	9.63	12	13	11	11	13	16	–	–
Property, Plant & Equipment	2.03	7.50	10	7.29	5.95	3.58	2.33	2.50	2.74	3.18	2.95	2.60	2.56	2.37	2.31	2.36	–	–
Gross Property, Plant & Equipment	–	–	–	16	13	8.60	8.58	8.35	8.21	8.31	7.66	6.94	6.63	6.23	5.92	–	–	–
Accumulated Depreciation	–	–	–	-8.44	-6.88	-5.02	-6.25	-5.85	-5.47	-5.13	-4.71	-4.34	-4.06	-3.86	-3.61	-3.39	–	–
Equity Method Investments	43	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	0	4.12	4.57	4.06	4.40	4.73	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	3.97	5.23	5.23	5.71	5.71	0.90	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	7.17	9.75	12	8.48	11	1.23	–	–	–	–	–	0	3.58	3.58	3.58	3.58	–	–
Deferred Tax Assets	–	0	7.31	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.00	0.31	1.16	1.16	0.61	0.24	–	–	–	–	–	–	–	–	–	–	–	–
Total Assets	60	63	92	88	89	31	12	21	34	13	15	16	17	17	19	22	–	–
Accounts Payable	–	14	8.64	5.91	7.03	3.77	0.43	0.44	0.56	2.16	0.99	0.67	1.01	1.30	0.89	0.49	–	–
Accrued Expenses	1.89	1.95	1.42	0.71	0.30	0.30	0.22	0.17	0.07	–	–	–	–	–	–	–	–	–
Short-Term Debt	–	3.21	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Debt	–	3.21	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Leases	0	1.21	0.95	0.30	0.66	0.33	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.28	1.99	3.28	4.19	1.31	–	–	0.11	0.74	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	1.50	1.70	2.38	2.50	2.03	0.17	0.10	0.21	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	2.66	2.12	2.59	2.07	2.50	1.56	0.41	0.77	1.05	0.39	1.04	0.89	0.77	0.85	0.49	0.70	–	–
Total Current Liabilities	53	32	21	16	16	6.29	0.93	4.23	1.81	6.84	4.53	5.24	4.62	4.91	7.85	8.24	–	–
Long-Term Debt	–	–	2.92	0	0.04	–	–	–	–	–	1.47	0.10	–	–	–	–	–	–
Long-Term Leases	0	3.76	4.24	4.26	4.20	4.40	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0	5.00	5.20	4.60	4.86	4.73	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	0	0.22	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	56	56	43	24	31	21	1.04	4.23	1.81	6.84	6.00	5.34	4.82	5.21	7.85	8.24	–	–
Total Debt	–	3.21	2.92	0	0.04	–	–	–	–	–	1.47	0.10	–	–	–	–	–	–
Preferred Stock	0	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Common Stock	0.00	0.00	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	–	–
Additional Paid-In Capital	126	130	119	109	105	62	60	59	58	56	56	55	44	43	42	41	–	–
Retained Earnings	-73	-58	-5.03	12	2.64	-3.63	-1.51	4.53	21	-20	-17	-13	-5.39	-5.79	-4.70	-1.99	–	–
Treasury Stock	-50	-64	-64	-58	-48	-47	-47	-47	-47	-31	-31	-31	-26	-26	-26	-25	–	–
Comprehensive Income & Other	-0.20	-0.20	-0.30	0.76	-0.18	-0.01	0.00	-0.02	-0.08	–	–	–	–	–	–	–	–	–
Shareholders' Equity	3.51	7.35	49	64	59	11	11	17	32	5.96	8.83	11	13	11	11	13	14	18
Total Equity	3.51	7.35	49	64	59	11	11	17	32	5.96	8.83	11	13	11	11	13	14	18
Total Liabilities & Equity	60	63	92	88	89	31	12	21	34	13	15	16	17	17	19	22	–	–
Shares Outstanding(shares)	8.97	2.99	1.75	1.57	1.50	1.12	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 16.8%
Operating margin: -404.5%
Net margin: -583.9%
Return on equity, FY2025: -271.5%

Financial strength

Current ratio: 0.05
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.0%

Valuation

P/E ratio: –
Price to sales: 0.03
Price to book: –
Dividend yield: –